Abbott Laboratories
ABT | NYSE
$108.72
+$2.52 (+2.37%)
Nov 2, 2026, 12:02 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 33.50 | 14.75 | 33.35 | 27.87 | 35.45 | 43.45 |
PEG Ratio | -0.65 | 0.11 | -2.05 | -36.88 | 0.62 | 2 |
PS Ratio | 4.94 | 4.67 | 4.76 | 4.41 | 5.80 | 5.61 |
PB Ratio | 4.20 | 4.11 | 4.94 | 5.25 | 6.98 | 5.92 |
P/FCF Ratio | 29.60 | 30.84 | 37.73 | 24.66 | 28.89 | 33.91 |
P/OCF Ratio | 22.88 | 22.89 | 26.29 | 20.09 | 23.72 | 24.57 |
OCF/S Ratio | 21.58 | 20.40 | 18.10 | 21.95 | 24.45 | 22.83 |
Debt / Equity Ratio | 0.29 | 0.32 | 0.41 | 0.49 | 0.54 | 0.61 |
Quick Ratio | 1.18 | 1.23 | 1.16 | 1.23 | 1.46 | 1.30 |
Current Ratio | 1.58 | 1.67 | 1.64 | 1.63 | 1.85 | 1.72 |
Asset Turnover | 0.51 | 0.52 | 0.55 | 0.59 | 0.57 | 0.48 |
Interest Coverage | 23.60 | 11.32 | 9.22 | 26.55 | 22.44 | 7.47 |
Return on Equity | 12.51% | 28.12% | 14.83% | 18.90% | 19.75% | 13.71% |
Return on Assets | 7.52% | 16.46% | 7.82% | 9.31% | 9.40% | 6.20% |
Return on Invested Capital | 8.44% | 9.89% | 9.10% | 11.36% | 12.56% | 7.79% |
Dividend Yield | 1.88% | 1.96% | 1.86% | 1.72% | 1.28% | 1.32% |
Payout Ratio | 63.09% | 28.62% | 62.14% | 47.73% | 45.28% | 56.95% |
FCF Payout Ratio | 61.15% | 67.56% | 80.54% | 46.48% | 39.98% | 49.44% |
Gross Profit Margin | 55.51% | 50.83% | 49.96% | 51.14% | 53.89% | 50.21% |
Net Profit Margin | 14.72% | 31.95% | 14.27% | 15.88% | 16.42% | 12.99% |
Pretax Profit Margin | 19.10% | 16.72% | 16.61% | 19.03% | 19.06% | 14.36% |
Operating Profit Margin | 18.16% | 16.27% | 16.04% | 19.16% | 21.36% | 15.29% |
FCF Margin | 16.68% | 15.14% | 12.61% | 17.88% | 20.08% | 16.54% |
EBITDA Margin | 26.90% | 25.83% | 26.44% | 27.23% | 28.23% | 26.01% |
Add to Watchlist
Select watchlists to add or remove ABT